News

Trial for patients with "unclassifiable" pulmonary fibrosis
25th May 2017

Trial for patients with "unclassifiable" pulmonary fibrosis

Dr Stephen Bianchi and a research team from the Clinical Research Facility, Pharmacy, Labs and Respiratory Function Unit, are starting a new clinical trial for patients who have a type of pulmonary fibrosis which, for reasons unknown, cannot ...

Read More

New COPD Trial: “SOPHOS”
27th April 2017

New COPD Trial: “SOPHOS”

Metered Dose Inhalers (MDIs) are the most common type of device to deliver inhaled drugs to patients with Chronic Obstructive Pulmonary Disease. Yet many COPD treatments, particularly dual and triple combinations, have proven difficult to develop ...

Read More

New Mesothelioma trial: “TARGET”
30th March 2017

New Mesothelioma trial: “TARGET”

Dr Leon Lewis and Dr Duneesha De Fonseka are participating in a trial for patients who are being investigated for suspected mesothelioma. The principal research question is whether a PET-CT-targeted biopsy is more likely to give a diagnosis than a...

Read More

1st UK patients in clinical trial for Idiopathic Lung Fibrosis
13th February 2017

1st UK patients in clinical trial for Idiopathic Lung Fibrosis

A study team from Sheffield Teaching Hospitals Respiratory Medicine have recruited the 1st and 2nd UK patients to take part in a clinical trial of a new type of treatment for the condition idiopathic lung fibrosis (IPF). Consultant Dr Stephen Bia...

Read More

Clinical Research Publications
3rd January 2017

Clinical Research Publications

The Sheffield Academic Directorate of Respiratory Medicine contributed to a number of clinical research articles which were published in 2016. A listing with links can be found on our Publications page: see www.lungsheffield.org/research...

Read More

Pulmonary Hypertension Patient Day
5th December 2016

Pulmonary Hypertension Patient Day

The Pulmonary Hypertension Association UK held a meeting for patients, their families, and staff from the Royal Hallamshire Hospital Pulmonary Vascular Disease Unit on 12th November at the Hilton Hotel in Sheffield. Staff from the PVDU gave presen...

Read More

New Trial of treatment for people with Idiopathic Pulmonary Fibrosis
5th December 2016

New Trial of treatment for people with Idiopathic Pulmonary Fibrosis

The STH Interstitial Lung Disease service led by Dr Stephen Bianchi has initiated a clinical trial sponsored by Boehringer-Ingelheim. The trial will investigate if combining two drugs, Nintedanib and Sildenafil, is effective in treatment of idiopa...

Read More

New clinical trial of treatment for Severe Asthma
5th December 2016

New clinical trial of treatment for Severe Asthma

Prof Ian Sabroe and the RHH Clinical Research Facility have initiated a clinical trial investigating Fevipiprant, a new treatment which can be taken orally as a tablet, developed by Novartis for people with severe asthma. Previous research has sho...

Read More

Patient and Public Involvement in Research Newsletter
7th October 2016

Patient and Public Involvement in Research Newsletter

the Sheffield Clinical Research Office has published its third Newsletter about Patient and Public Involvement in clinical research. Click here for details http://www.lungsheffield.org/files/document/39/PPI%20Newsletter%203rd%20ed..pdf

Read More

New trial using advanced MR Imaging to investigate effect of inhaled treatments for COPD
5th September 2016

New trial using advanced MR Imaging to investigate effect of inhaled treatments for COPD

A trial sponsored by Novartis will build on previous research involving STH Respiratory Medicine (Dr Rod Lawson) and the University of Sheffield (Prof Jim Wild). The trial will study the effects of a combination inhaled drug therapy (LABA/LAMA) in...

Read More